First human test for new drug formula
NCT ID NCT05796479
Summary
This early-stage study aimed to understand how two slightly different versions of the experimental drug amlitelimab are processed by the body and to check for side effects. It involved 32 healthy adult volunteers who received a single injection. The main goal was to compare how the two drug versions behave in healthy people to help plan future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Pharmacology of Miami-Site Number: 8400001
Hialeah, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.